Non Invasive Assessment of Heart Failure

• Status: Not yet recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

1. To Identify the role of aldosterone antagonist in patients of heart failure with preserved ejection fraction.

2. Portray the health profile of heart failure patients admitted in internal medicine department either heart failure with reduced ejection fraction or heart failure with preserved ejection fraction.

3. To compare between patients of right and left sided heart failure by biomarkers and parameters of echocardiographgy

4. Vitamin D and its relation to cardiovascular disease and heart failure.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Mineralocorticoid Receptor Antagonists

Criteria

Inclusion Criteria:

1. clinical diagnosed heart failure dyspnea grade III or IV

2. Heart failure with ejecton fraction ≤40

Exclusion Criteria:

1. Acute coronary syndrome.

2. Active infection

3. Chronic kidney diseased patients

4. Conn's disease